Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap W Groothoff

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 22, 2025
Long-term Lumasiran Therapy Final Results from a Phase 2 Open-label Extension Study in Primary HyperoxaluriaYaacov Frishberg, Jaap W Groothoff, Sally-Anne Hulton, et al.
Kidney International|February 19, 2002
Mortality and causes of death of end-stage renal disease in children: a Dutch cohort studyJaap W Groothoff, Mariken P Gruppen, Martin Offringa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2015
Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA RegistryDanilo Lofaro, Kitty J Jager, Ameen Abu-Hanna, et al.
BMC Nephrology|August 7, 2013
Low agreement between cardiologists diagnosing left ventricular hypertrophy in children with end-stage renal diseaseNikki J Schoenmaker, Johanna H van der Lee, Jaap W Groothoff, et al.
Kidney International|April 18, 2021
A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3Cristina Martin-Higueras, Sander F Garrelfs, Jaap W Groothoff, et al.
Kidney International Reports|July 9, 2025
PHYOX3: Nedosiran Long-Term Safety and Efficacy in Patients With Primary Hyperoxaluria Type 1John C Lieske, Gema Ariceta, Jaap W Groothoff, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 23, 2007
Altered proximal aortic stiffness and endothelin plasma levels in diabetic patients with end-stage renal diseaseDimitrios Karakitsos, Alexandros P Patrianakos, Frangiskos I Parthenakis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 4, 2025
Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1Yaacov Frishberg, Jeffrey M Saland, John C Lieske, et al.
Kidney International|August 5, 2011
Demographics of blood pressure and hypertension in children on renal replacement therapy in EuropeA Marijn Kramer, Karlijn J van Stralen, Kitty J Jager, et al.
Pediatric Nephrology (Berlin, Germany)|December 24, 2017
Renal replacement therapy for children throughout the world: the need for a global registrySophie Ploos van Amstel, Marlies Noordzij, Bradley A Warady, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 22, 2025
Long-term Lumasiran Therapy Final Results from a Phase 2 Open-label Extension Study in Primary HyperoxaluriaYaacov Frishberg, Jaap W Groothoff, Sally-Anne Hulton, et al.
Kidney International|February 19, 2002
Mortality and causes of death of end-stage renal disease in children: a Dutch cohort studyJaap W Groothoff, Mariken P Gruppen, Martin Offringa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2015
Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA RegistryDanilo Lofaro, Kitty J Jager, Ameen Abu-Hanna, et al.
BMC Nephrology|August 7, 2013
Low agreement between cardiologists diagnosing left ventricular hypertrophy in children with end-stage renal diseaseNikki J Schoenmaker, Johanna H van der Lee, Jaap W Groothoff, et al.
Kidney International|April 18, 2021
A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3Cristina Martin-Higueras, Sander F Garrelfs, Jaap W Groothoff, et al.
Kidney International Reports|July 9, 2025
PHYOX3: Nedosiran Long-Term Safety and Efficacy in Patients With Primary Hyperoxaluria Type 1John C Lieske, Gema Ariceta, Jaap W Groothoff, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 23, 2007
Altered proximal aortic stiffness and endothelin plasma levels in diabetic patients with end-stage renal diseaseDimitrios Karakitsos, Alexandros P Patrianakos, Frangiskos I Parthenakis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 4, 2025
Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1Yaacov Frishberg, Jeffrey M Saland, John C Lieske, et al.
Kidney International|August 5, 2011
Demographics of blood pressure and hypertension in children on renal replacement therapy in EuropeA Marijn Kramer, Karlijn J van Stralen, Kitty J Jager, et al.
Pediatric Nephrology (Berlin, Germany)|December 24, 2017
Renal replacement therapy for children throughout the world: the need for a global registrySophie Ploos van Amstel, Marlies Noordzij, Bradley A Warady, et al.
Pageof 15